Anticancer Therapies – Multimedia
Video
Key Factors To Accelerate Drug Discovery
Speaking at Drug Discovery & Development online symposium 2021, Pei Liu from GenScript, presented her talk on monoclonal antibodies.
App Note / Case Study
Early Screening of Pancreatic Cancer Immunotherapy Target Candidates
It has proven difficult to accurately identify the biological targets of cancer, which are necessary for the development of successful therapeutics including novel immunotherapies, such as those based on chimeric antigen receptor (CAR) T cells.
Listicle
Five Ways To Measure Immunotherapy Potency
This listicle highlights five commonly used cell viability assays and their benefits and limitations in immunotherapy potency testing.
Video
Development and Implementation of Clinical Proteomics for Precision Oncology Applications and Therapeutic Drug Development
Speaking at The Landscape of Cancer Research 2021, Prof. Emanuel Petricoin from The George Mason University, presented his talk on pharmacoproteomics.
Video
Antibody-Based Therapeutics Against Cancer: Emerging Targets and Research Tools
Speaking at The Landscape of Cancer Research 2021 online symposium, Tianzi Li delivered her talk on the discovery of novel targets and the use of antibodies in cancer therapy.
Video
How COVID-19 Vaccines Are Accelerating New Cancer Treatments
The Cancer Research Institute hosted a special event with mRNA vaccine pioneers and 2021 Coley Award Winners. In this interview, the honorees shared their thoughts on how mRNA vaccine technology will transform cancer treatment in the future.
App Note / Case Study
Gene Modification for Cell Therapy Applications
The clinical success of CAR T-cell therapy has spurred increased interest and investments in the advanced therapeutics industry.
eBook
Evaluating Immune Cell Therapy Potency
Download this eBook to learn more about the tools available for evaluating immune cell therapy potency.
App Note / Case Study
Expansion of Specific Lymphocyte Populations
Expansion of Specific Lymphocyte Populations With 4Cell® Nutri-T Xeno-Free, Serum-Free Medium
The success of CAR T-cell therapy requires efficient expansion of specific subpopulations of patient-derived immune cells.
The success of CAR T-cell therapy requires efficient expansion of specific subpopulations of patient-derived immune cells.
Whitepaper
PD-1/PD-L1 Combination Therapy in Cancer Treatment
Cancer immunotherapy, especially the use of immune checkpoint inhibitors, has been successful in improving the treatment landscape of malignancies.
Advertisement
